Shandong Sinobioway Biomedicine Co.,Ltd.’s Net Profit Dropped 43.4% in First Three Quarters of 2023

Shandong Sinobioway Biomedicine Co.,Ltd. (山东未名生物医药股份有限公司) (002581.SZ) reported a net profit of 38.5 million yuan in the first three quarters of 2023, down 43.4% year-on-year.

Meanwhile, the company posted 338.3 million yuan in revenue, up 22.8% year-on-year.

At the end of the reporting period, it had 2.8 billion yuan in total assets and 282.7 million yuan in total liabilities, with a liability-to-asset ratio of 10.1%.